Epilepsy in children
148 results
1 - 100
Care delivery and self‐management strategies for children with epilepsy- Self-management education for children with epilepsy: Cochrane systematic review
- Service delivery, behavioural, and self‐management interventions for children with epilepsy
- Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes: Cochrane systematic review
- Stiripentol add‐on therapy for drug‐resistant focal epilepsy
- Immunomodulatory interventions for focal epilepsy
- Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child
- Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms: Cochrane systematic review
- Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
- Levetiracetam add‐on for drug‐resistant focal epilepsy
- Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
- Polyunsaturated fatty acid supplementation for drug‐resistant epilepsy
- Clonazepam add‐on therapy for drug‐resistant epilepsy
- Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy
- Ketogenic diets for drug‐resistant epilepsy
- Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
- Lacosamide add‐on therapy for focal epilepsy
- Oxcarbazepine add-on for drug-resistant partial epilepsy: Cochrane systematic review
- Common antiepileptic drugs in pregnancy in women with epilepsy: Cochrane systematic review
- Subpial transection surgery for epilepsy
- Pregabalin add‐on for drug‐resistant focal epilepsy
- Cenobamate add‐on therapy for drug‐resistant focal epilepsy
- Early versus late antiepileptic drug withdrawal for people with epilepsy in remission: Cochrane systematic review
- Clonazepam monotherapy for treating people with newly diagnosed epilepsy
- Rufinamide add‐on therapy for drug‐resistant epilepsy
- Eslicarbazepine acetate monotherapy for epilepsy
- Lamotrigine add‐on therapy for drug‐resistant focal epilepsy
- Carisbamate add‐on therapy for drug‐resistant focal epilepsy
- Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy
- Acupuncture for epilepsy
- Brivaracetam add‐on therapy for drug‐resistant epilepsy
- Topiramate add‐on therapy for drug‐resistant focal epilepsy
- Rapid versus slow withdrawal of antiepileptic drugs
- Tiagabine add‐on therapy for drug‐resistant focal epilepsy
- Psychological treatments for people with epilepsy
- Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review: Cochrane systematic review
- Neuropsychological and psychological interventions for people with newly diagnosed epilepsy
- Melatonin as add‐on treatment for epilepsy
- Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy
- Vigabatrin add‐on therapy for drug‐resistant focal epilepsy
- Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
- Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
- Sulthiame add‐on therapy for epilepsy
- Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
- Vigabatrin versus carbamazepine monotherapy for epilepsy
- Pregabalin monotherapy for epilepsy: Cochrane systematic review
- EEG for children with complex febrile seizures
- Gabapentin add‐on treatment for drug‐resistant focal epilepsy
- Perampanel add‐on for drug‐resistant focal epilepsy
- Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
- Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review
- Vagus nerve stimulation for focal seizures